GlaxoSmithKline Blocks Sale Of Generic Flonase
Filed in archive Drugs, Vaccines and Therapeutics , Patents and Intellectual Property Rights on February 28, 2006
A federal judge in Baltimore issued a 10-day restraining order, blocking the shipment and sales of Fluticasone Propionate Nasal Spray (from Roxane Laboratories Inc.'s , FDA-approved last week) and Par Pharmaceutical Companies Inc.'s generic version of Flonase (GlaxoSmithKline), a nasal spray that treats allergic and nonallergic nasal symptoms.
GlaxoSmithKline obtained the restraining order one day after the company sued the FDA for allegedly ailed to follow its own regulations in approving the Flonase generic and failed to apply the same quality standards.
See full story from LA Times.
Tags: allergies nasal biotech generic flonase generic+flonase glaxosmithkline+blocks sale+generic
Vote for GlaxoSmithKline Blocks Sale Of Generic Flonase:
|
Rating: 8.25 out of 4 vote(s) cast.
|
Response from:
Diane
(03/09/08 5:54pm)
How do you initially prime. What does it mean?
Response from:
Chris
(09/06/10 9:01pm)
Generic for flonase called Fluticasone manufactured by Glaxo Smithkline is available online at International Drug Mart.
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells